Breakthrough device promises significantly improved patient recovery after colorectal surgery....
Chief Executive Officer Chris Richardson to Speak at LSI Emerging Medtech Summit
Chris Richardson, CEO of SafeHeal, will be presenting an overview of the benefits of Colovac to strategic partners....
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
SafeHeal, a leading innovator in the field of digestive surgery, announces today that its unique Colovac bypass sheath has received the CE-mark....
SafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath
SafeHeal, an innovator in the field of digestive surgery, has concluded its first-in-human clinical study for its novel Colovac bypass sheath in patie...
SAFEHEAL starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy
The study will evaluate safety and efficacy of the Colovac bypass device for ostomy-free anastomosis protection following colorectal surgery....
SafeHeal Appoints Dr. Karl Blohm as CEO to Prepare for Launch and Commercialization
SafeHeal, an MD Start-ed company and a pioneer in the prevention of digestive surgery complications, today announced the appointment of Karl Blohm, Ph...